{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:30:10Z","timestamp":1784770210386,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Zhejiang Province","award":["LQ22H160006"],"award-info":[{"award-number":["LQ22H160006"]}]},{"name":"Zhejiang Provincial National key research and development program","award":["2019C03037"],"award-info":[{"award-number":["2019C03037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>With recent advances in gene sequencing technology, more than 60 genetic mutations associated with very early onset inflammatory bowel disease (VEO-IBD) have been reported. Most of the genes are associated with immune deficiencies. The Myosin 5B (<jats:italic>MYO5B<\/jats:italic>) gene is primarily involved in cell motility and material transport which is associated with congenital intractable diarrhea and cholestasis. No studies have examined the relationship between the <jats:italic>MYO5B<\/jats:italic> gene and VEO-IBD. We report a case of a child with a mutation in the <jats:italic>MYO5B<\/jats:italic> gene who was diagnosed with VEO-IBD, then we investigated the association between the <jats:italic>MYO5B<\/jats:italic> gene and VEO-IBD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 7-month-old baby girl with a chief complaint of \u201cblood in the stool for more than 4 months and vaginal pus and blood discharge for 3 weeks\u201d was diagnosed with VEO-IBD, and her symptoms improved after treatment with mesalazine. The whole-exome sequencing was performed with peripheral blood. Immunohistochemistry was performed on the terminal ileal tissue. Western blotting, quantitative polymerase chain reaction (Q-PCR) and immunofluorescence were performed with cultured organoid tissue from the terminal ileum. Whole-exome sequencing identified heterozygous missense of <jats:italic>MYO5B<\/jats:italic> variant of unknown significance (p. [I769N]; [T1546M]). Immunohistochemistry revealed a significant decrease in the expression of <jats:italic>MYO5B<\/jats:italic> protein in the terminal ileum of the child with <jats:italic>MYO5B<\/jats:italic> mutation; Q-PCR revealed a decrease in the mRNA levels of occludin and ZO-1 and both the mRNA levels and protein levels of <jats:italic>MYO5B<\/jats:italic> was downregulated in the patient. Immunofluorescence images showed that <jats:italic>MYO5B<\/jats:italic> gene mutation disrupted the apical delivery of transporters SGLT1, NHE3 and AQP7.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>MYO5B gene mutation leading to the downregulation of <jats:italic>MYO5B<\/jats:italic> protein may promote the occurrence of VEO-IBD by decreasing mRNA and protein levels of intestinal tight junction genes and dislocating the apical transporters.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-024-01962-z","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T10:03:48Z","timestamp":1721124228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report"],"prefix":"10.1186","volume":"17","author":[{"given":"Yue","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"1962_CR1","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/ibd\/izz259","volume":"26","author":"J Ouahed","year":"2020","unstructured":"Ouahed J, Spencer E, Kotlarz D, Shouval DS, Kowalik M, Peng K, et al. Very early onset inflammatory bowel disease: a clinical Approach with a focus on the role of Genetics and underlying Immune deficiencies. Inflamm Bowel Dis. 2020;26:820\u201342.","journal-title":"Inflamm Bowel Dis"},{"key":"1962_CR2","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.gastro.2014.07.023","volume":"147","author":"HH Uhlig","year":"2014","unstructured":"Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147:990\u2013e10073.","journal-title":"Gastroenterology"},{"key":"1962_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.iac.2018.08.008","volume":"39","author":"JR Kelsen","year":"2019","unstructured":"Kelsen JR, Russo P. Sullivan. Early-Onset Inflammatory Bowel Disease. Immunol Allergy Clin North Am. 2019;39:63\u201379.","journal-title":"Immunol Allergy Clin North Am"},{"key":"1962_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jpeds.2004.08.043","volume":"146","author":"MB Heyman","year":"2005","unstructured":"Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005;146:35\u201340.","journal-title":"J Pediatr"},{"key":"1962_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.gendis.2019.10.003","volume":"7","author":"J Nameirakpam","year":"2020","unstructured":"Nameirakpam J, Rikhi R, Rawat SS, Sharma J, Suri D. Genetics on early onset inflammatory bowel disease: an update. Genes Dis. 2020;7:93\u2013106.","journal-title":"Genes Dis"},{"key":"1962_CR6","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/hep.31430","volume":"72","author":"ISCDQ Li","year":"2020","unstructured":"Li ISCDQ, Qiu YL, Wang JS, Overeem AW. Unequal effects of myosin 5B mutations in liver and intestine determine the clinical presentation of Low-Gamma-Glutamyltransferase Cholestasis. Hepatology. 2020;72:1461\u20138.","journal-title":"Hepatology"},{"key":"1962_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jcmgh.2022.04.015","volume":"14","author":"DM Bowman","year":"2022","unstructured":"Bowman DM, Kaji I, Goldenring JR. Altered MYO5B function underlies microvillus inclusion disease: opportunities for intervention at a Cellular Level. Cell Mol Gastroenterol Hepatol. 2022;14:553\u201365.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1962_CR8","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1073\/pnas.1010754108","volume":"108","author":"JT Roland","year":"2011","unstructured":"Roland JT, Bryant DM, Datta A, Itzen A, Mostov KE. Goldenring. Rab GTPase-Myo5B complexes control membrane recycling and epithelial polarization. Proc Natl Acad Sci USA. 2011;108:2789\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1962_CR9","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1053\/j.gastro.2018.08.025","volume":"155","author":"AC Engevik","year":"2018","unstructured":"Engevik AC, Kaji I, Engevik MA, Meyer AR, Weis VG, Goldstein A, et al. Loss of MYO5B leads to reductions in na(+) absorption with maintenance of CFTR-Dependent Cl(-) secretion in Enterocytes. Gastroenterology. 2018;155:1883\u2013e189710.","journal-title":"Gastroenterology"},{"key":"1962_CR10","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1053\/j.gastro.2020.06.008","volume":"159","author":"I Kaji","year":"2020","unstructured":"Kaji I, Roland JT, Watanabe M, Engevik AC, Goldstein AE, Hodges CA, et al. Lysophosphatidic acid increases maturation of Brush Borders and SGLT1 activity in MYO5B-deficient mice, a model of microvillus inclusion disease. Gastroenterology. 2020;159:1390\u2013e140520.","journal-title":"Gastroenterology"},{"key":"1962_CR11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.stem.2018.11.016","volume":"23","author":"M Fujii","year":"2018","unstructured":"Fujii M, Matano M, Toshimitsu K, Takano A, Mikami Y, Nishikori S, et al. Human intestinal organoids maintain Self-Renewal Capacity and Cellular Diversity in niche-inspired Culture Condition. Cell Stem Cell. 2018;23:787\u2013e7936.","journal-title":"Cell Stem Cell"},{"key":"1962_CR12","doi-asserted-by":"publisher","first-page":"C405","DOI":"10.1152\/ajpcell.00300.2017","volume":"317","author":"M Almeqdadi","year":"2019","unstructured":"Almeqdadi M, Mana MD, Roper J, Yilmaz H. Gut organoids: mini-tissues in culture to study intestinal physiology and disease. Am J Physiol Cell Physiol. 2019;317:C405\u201319.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1962_CR13","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1172\/JCI71651","volume":"124","author":"BC Knowles","year":"2014","unstructured":"Knowles BC, Roland JT, Krishnan M, Tyska MJ, Lapierre LA, Dickman PS, et al. Myosin vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease. J Clin Invest. 2014;124:2947\u201362.","journal-title":"J Clin Invest"},{"key":"1962_CR14","doi-asserted-by":"crossref","unstructured":"Vij M. and V. Shah. Compound heterozygous myosin 5B (Myo5b) mutation with early Onset Progressive Cholestasis and no intestinal failure. Fetal Pediatr Pathol. 2021:1\u20137.","DOI":"10.1080\/15513815.2021.1959690"},{"key":"1962_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/MPG.0b013e3182353773","volume":"54","author":"MR Golachowska","year":"2012","unstructured":"Golachowska MR, van Dael CM, Keuning H, Karrenbeld A, Hoekstra D, Gijsbers CF, et al. MYO5B mutations in patients with microvillus inclusion disease presenting with transient renal Fanconi syndrome. J Pediatr Gastroenterol Nutr. 2012;54:491\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1962_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/hep.26974","volume":"60","author":"M Girard","year":"2014","unstructured":"Girard M, Lacaille F, Verkarre V, Mategot R, Feldmann G, Grodet A, et al. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease. Hepatology. 2014;60:301\u201310.","journal-title":"Hepatology"},{"key":"1962_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.fsi.2020.02.009","volume":"99","author":"LF Jiao","year":"2020","unstructured":"Jiao LF, Dai TM, Zhong SQ, Jin M, Sun P, Zhou QC. Vibrio parahaemolyticus infection impaired intestinal barrier function and nutrient absorption in Litopenaeus vannamei. Fish Shellfish Immunol. 2020;99:184\u20139.","journal-title":"Fish Shellfish Immunol"},{"key":"1962_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11906-019-0964-5","volume":"21","author":"M Tanaka","year":"2019","unstructured":"Tanaka M, Itoh H. Hypertension as a metabolic disorder and the Novel role of the gut. Curr Hypertens Rep. 2019;21:63.","journal-title":"Curr Hypertens Rep"},{"key":"1962_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","volume":"94","author":"GP Ramos","year":"2019","unstructured":"Ramos GP, Papadakis KA. Mechanisms of Disease: Inflammatory Bowel diseases. Mayo Clin Proc. 2019;94:155\u201365.","journal-title":"Mayo Clin Proc"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-024-01962-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-024-01962-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-024-01962-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T10:05:49Z","timestamp":1721124349000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-024-01962-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1962"],"URL":"https:\/\/doi.org\/10.1186\/s12920-024-01962-z","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"assertion":[{"value":"7 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The analysis of human samples was approved by the Medical Ethical Committee of Children\u2019s Hospital, Zhejiang University School of Medicine under 2019-IRB-109. Informed consent to participate was obtained from all the participants and the parents of the patient in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent were obtained from all the participants and legally authorized guardian\u2019s of patient for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}